Yahoo Finance

United States Non-Invasive Prenatal Testing Market Report 2025-2033: Illumina, Roche, and Natera, which have Established Themselves as Leaders through Robust Research and ...

U.S. Non-Invasive Prenatal Testing (NIPT) Market · GlobeNewswire Inc. Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "United States Non-Invasive Prenatal Testing (NIPT) Market Report 2025: Industry ...
indiafilings.com

GENPATH LIFE SCIENCES PRIVATE LIMITED

What is the address for GENPATH LIFE SCIENCES PRIVATE LIMITED ? The corporate office of GENPATH LIFE SCIENCES PRIVATE LIMITED is situated at N 1/59-7, Shivpur Colony Nagwa, Lanka NA Varanasi Uttar ...
International Livestock Research Institute

New consortium aims to better diagnose, monitor and clinically manage current and future epidemics in Africa

Over the next four years, the newly launched GenPath Africa (Genomic surveillance to control pathogen infections in Africa) project will receive five million euros from the European Union under its ...
Seeking Alpha

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

CINtec ® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, N.J., Feb. 9, 2023 /PRNewswire/ -- BioReference® Health LLC, one of the largest full-service ...
indiafilings.com

GENPATH CONSULTANTS AND TECHNOLOGIES (OPC) PRIVATE LIMITED

GENPATH CONSULTANTS AND TECHNOLOGIES (OPC) PRIVATE LIMITED is a Private Limited Company, governed by the Companies Act as a company limited by shares. Classified as a Non-government company, it is ...
IEEE

GenPath - A Genetic Multi-Round Path Planning Algorithm for Aerial Vehicles

Abstract: The past few years have witnessed unprecedented proliferation of Unmanned Aerial Vehicles (UAVs).They are employed in a growing number of scenarios, from parcel delivery to search and rescue ...
Pharmabiz

BioReference Labs buys US Ariosa centralized laboratory prenatal testing business from Roche

BioReference Laboratories, Inc., an OPKO Health company announced the acquisition of the US Ariosa centralized laboratory prenatal testing business from Roche. Ariosa's non invasive prenatal screening ...
NJBIZ

BioReference acquires Roche’s Ariosa centralized lab prenatal testing biz

BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
The Trentonian

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S ...
360dx

BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche

Ariosa's noninvasive prenatal screening test, the Harmony Prenatal Test, has been performed in more than 1.5 million patients. The acquisition will complement BioReference's specialty health division ...
Nasdaq

OPKO Health's BioReference Laboratories Introduces NGS Assay

OPKO Health, Inc.’s OPK BioReference Laboratories, Inc. along with its specialty oncology division, GenPath, recently launched OnkoSight Advanced. It is a next-generation sequencing (NGS) assay that ...